Arthur F. Kluge

Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours

Loren Lasko, Clarissa G. Jakob, Rohinton Edalji et al. · Nature · 2017 · 813 citations · Full text

Lineage-specific Tumours, Medicine, Immune Checkpoint Inhibitor +8

Targeted covalent drugs of the kinase family

Juswinder Singh, Russell C. Petter, Arthur F. Kluge · Current Opinion in Chemical Biology · 2010 · 175 citations

Medicinal Chemistry, Drug Target, Drug Targeting +5

Prostaglandins. X. Synthesis of prostaglandin models and prostaglandins by conjugage addition of a functionalized organocopper reagent

Arthur F. Kluge, Karl G. Untch, John H. Fried · Journal of the American Chemical Society · 1972 · 161 citations

Bioorganic Chemistry, Engineering, Chemical Analysis +16

A Three-Hybrid Approach to Scanning the Proteome for Targets of Small Molecule Kinase Inhibitors

Frank Becker, Krishna K. Murthi, Chase C. Smith et al. · Chemistry & Biology · 2004 · 136 citations · Full text

Molecular Docking, Three-hybrid Approach, Drug Target +9

Novel highly selective inhibitors of ubiquitin specific protease 30 (USP30) accelerate mitophagy

Arthur F. Kluge, Bharat Lagu, Pranab Maiti et al. · Bioorganic & Medicinal Chemistry Letters · 2018 · 122 citations · Full text

Protease Inhibitors, Cell Autophagy, Mitophagy +8